EP 2152234 A1 20100217 - LYOPHILIZED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING AND USING SAME
Title (en)
LYOPHILIZED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING AND USING SAME
Title (de)
LYOPHILISIERTE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERFAHREN ZU IHRER HERSTELLUNG UND VERWENDUNG
Title (fr)
COMPOSITIONS PHARMACEUTIQUES LYOPHILISÉES ET PROCÉDÉS DE FABRICATION ET D'UTILISATION CORRESPONDANT
Publication
Application
Priority
- US 2008004755 W 20080411
- EP 07290443 A 20070411
- EP 08742816 A 20080411
Abstract (en)
[origin: EP1980240A1] The present invention relates to a new lyophilized pharmaceutical composition capable of adhering to oral mucosal tissue for an extended period of time for delivering active pharmaceutical ingredient through the oral mucosal tissue using transmucosal absorption.
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/14 (2006.01); A61K 9/19 (2006.01); A61K 31/135 (2006.01); A61K 31/4045 (2006.01); A61K 31/4178 (2006.01); A61K 38/095 (2019.01)
CPC (source: EP)
A61K 9/006 (2013.01); A61K 9/19 (2013.01); A61K 31/135 (2013.01); A61K 31/4045 (2013.01); A61K 31/4178 (2013.01); A61K 31/435 (2013.01); A61K 38/095 (2018.12); A61K 38/23 (2013.01); A61K 38/26 (2013.01); A61K 38/28 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01); A61P 1/08 (2017.12); A61P 13/02 (2017.12); A61P 25/04 (2017.12); A61P 25/06 (2017.12)
Citation (search report)
See references of WO 2008127679A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
EP 1980240 A1 20081015; CA 2683603 A1 20081023; EP 2152234 A1 20100217; JP 2010523678 A 20100715; JP 2015028030 A 20150212; MX 2009010989 A 20091029; WO 2008127679 A1 20081023
DOCDB simple family (application)
EP 07290443 A 20070411; CA 2683603 A 20080411; EP 08742816 A 20080411; JP 2010503077 A 20080411; JP 2014165583 A 20140815; MX 2009010989 A 20080411; US 2008004755 W 20080411